Managing Adverse Effects of Obesity Medications

Managing Adverse Effects of Obesity Medicatio...

Up next

Resistant Hypertension: Diagnosis and Management

Resistant hypertension affects about 10% of those treated for hypertension. Managing it involves lowering sodium intake, exercising, losing weight, reducing alcohol consumption, and using optimal diuretics, combination pills, and mineralocorticoid antagonists. Author Michel Azizi ...  Show more

Update on Peanut Allergy

Peanut allergy affects about 2% of people in the US and most commonly develops in early childhood. Peanut introduction during infancy has led to decreased prevalence of peanut allergy. Author Elissa Abrams, MD, MPH, of the University of Manitoba joins JAMA Deputy Editor Kristin W ...  Show more

Recommended Episodes

Obesity Rx: How to Use New Medications in Clinic
Medscape InDiscussion: Obesity

Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more. Relevant disclosures can be found with the episode ...  Show more

Obesity as a Disease: Changing the Paradigm
Medscape InDiscussion: Obesity

How can you change the paradigm on obesity as a disease? In this episode, Drs Robert Kushner and Donna Ryan dig into the science, speak about bias within the healthcare system, and advocate for better patient care. Relevant disclosures can be found with the episode show notes on ...  Show more

National Obesity Care Week with Dr. Chandra
cmwlweightlosstalk's podcast

Join Dr. Chandra as she discusses the importance of understanding the risks of obesity and how we can address the disease during National Obesity Care Week. 

America’s Obesity Crisis: Is Ozempic a Cure or a Cover-Up? | Calley Means and Tyna Moore
The Dr. Hyman Show

The rise in obesity and chronic disease over the years is alarming. Rather than genetics, it can be attributed to environmental and dietary changes, emphasizing the role of food quality over quantity. And while GLP-1 agonists like Ozempic may show some promise in addressing metab ...  Show more